[Federal Register Volume 61, Number 77 (Friday, April 19, 1996)]
[Notices]
[Pages 17304-17305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9688]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Vaccine Advisory Committee (NVAC), Subcommittee on 
Vaccine Safety and the Advisory Commission on Childhood Vaccines (ACCV) 
Subcommittee on Vaccine Safety; Subcommittee on Immunization Coverage; 
and Subcommittee on Future Vaccines: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 8:30 a.m-2 p.m., May 6, 1996; 8:30 a.m.-1 p.m., 
May 7, 1996.
    Place: Hubert H. Humphrey Building, Room 703A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
so they can be escorted to the meeting. Entrance to the meeting at 
other times during the day cannot be assured.
    Purpose: The Committee shall advise and make recommendations to 
the Director of the National Vaccine Program on matters related to 
the Program responsibilities.
    Matters to be Discussed: The Committee will receive a report 
from the Subcommittee on Immunization Coverage on how responsibility 
for immunization is shared, accountability for immunization under 
managed care, and assimilating additions to the vaccine schedule; a 
report from the joint Subcommittee on Vaccine Safety on adverse

[[Page 17305]]

events in adults; Vaccine Adverse Effects Registry update; varicella 
vaccine; hepatitis A vaccine post-marketing surveillance; long-term 
stable funding for the Large-Linked Database; discussion of the 
draft NVAC paper on Vaccine Research Partnerships; serologic 
correlates of DTaP protection; update on NVAC funding of unmet 
needs; children's vaccine initiative; the immunization registry; the 
NVPO directorship; and the NVAC committee nominations.

    Name: Subcommittee on Vaccine Safety and the Advisory Commission 
on Childhood Vaccines Subcommittee on Vaccine Safety.
    Time and Date: 2:30 p.m.-5 p.m., May 6, 1996.
    Place: Hubert H. Humphrey Building, Room 425A., 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This joint ACCV/NVAC subcommittee will review issues 
relevant to vaccine safety and adverse reactions to vaccines.
    Matters to be Discussed: The Subcommittee will discuss the 
report from the Task Force on Safer Childhood Vaccines interagency 
working group; expanding the Vaccine Injury Compensation Program to 
include adult immunizations and immunizations in special 
populations; visibility of a trust fund and administrative 
resources; and lessons from the swine flue experience.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2:30 p.m.-5 p.m., May 6, 1996.
    Place: Hubert H. Humphrey Building, Room 423A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Immunization Coverage will identify 
strategies and policy options by which to further improve the levels 
of immunization coverage.
    Matters to be Discussed: The Subcommittee will discuss financing 
of an immunizations forum and prioritize findings from the forum, 
and previous committee work.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2:30 p.m.-5 p.m., May 6, 1996.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Future Vaccines will develop policy 
options and guide national activities which will lead to accelerated 
development, licensure, and best use of new vaccines in the simplest 
possible immunization schedules.
    Matters to be Discussed: The Subcommittee will identify the 
matrix of interactions and partnerships, via specific case studies; 
describe the process of priority-setting by each of the members of 
the vaccine research and development community, and define barriers 
to new vaccine development.
    Agenda items for each meeting are subject to change as 
priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, National Vaccine Program Office, CDC, 1600 
Clifton Road, NE, M/S D50, Atlanta, Georgia 30333, telephone 404/
639-7250.

    Dated: April 15, 1996.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 96-9688 Filed 4-18-96; 8:45 am]
BILLING CODE 4163-18-M